HUP0002644A2 - Aldóz reduktáz inhibítort és ACE inhibitort tartalmazó gyógyászati készítmények - Google Patents

Aldóz reduktáz inhibítort és ACE inhibitort tartalmazó gyógyászati készítmények

Info

Publication number
HUP0002644A2
HUP0002644A2 HU0002644A HUP0002644A HUP0002644A2 HU P0002644 A2 HUP0002644 A2 HU P0002644A2 HU 0002644 A HU0002644 A HU 0002644A HU P0002644 A HUP0002644 A HU P0002644A HU P0002644 A2 HUP0002644 A2 HU P0002644A2
Authority
HU
Hungary
Prior art keywords
inhibitor
aldose reductase
phartmaceutical
compositions
ace
Prior art date
Application number
HU0002644A
Other languages
English (en)
Inventor
Norman Eugene Cameron
Frank Carey
Mary Anne Cotter
David Patric Tuffin
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of HUP0002644A2 publication Critical patent/HUP0002644A2/hu
Publication of HU224009B1 publication Critical patent/HU224009B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány szerinti gyógyászati készítmények egy aldóz reduktázinhibitort (ARI) és egy angiotenzinátalakító enzim (ACE) inhibitorttartalmaznak, egy vagy több gyógyászatilag alkalmazható hígító-,hordozó- és/vagy egyéb segédanyaggal együtt. Ezek a gyógyászatikészítmények a diabetes mellitus (cukorbetegség) okozta komplikációkmegelőzésére és kezelésére hasznosíthatók. Ó
HU0002644A 1997-07-08 1998-07-02 Aldóz reduktáz inhibitort és ACE inhibitort tartalmazó gyógyászati készítmények HU224009B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714274.9A GB9714274D0 (en) 1997-07-08 1997-07-08 Pharmaceutical composition
PCT/GB1998/001959 WO1999002189A1 (en) 1997-07-08 1998-07-02 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor

Publications (2)

Publication Number Publication Date
HUP0002644A2 true HUP0002644A2 (hu) 2000-12-28
HU224009B1 HU224009B1 (hu) 2005-04-28

Family

ID=10815469

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002644A HU224009B1 (hu) 1997-07-08 1998-07-02 Aldóz reduktáz inhibitort és ACE inhibitort tartalmazó gyógyászati készítmények

Country Status (28)

Country Link
US (1) US6337327B1 (hu)
EP (1) EP0991424B1 (hu)
JP (1) JP2002509540A (hu)
KR (1) KR20010015551A (hu)
CN (1) CN1186097C (hu)
AT (1) ATE205402T1 (hu)
AU (1) AU746211B2 (hu)
BR (1) BR9810570A (hu)
CA (1) CA2292451A1 (hu)
CZ (1) CZ290276B6 (hu)
DE (1) DE69801661T2 (hu)
DK (1) DK0991424T3 (hu)
ES (1) ES2163283T3 (hu)
GB (1) GB9714274D0 (hu)
HK (1) HK1028876A1 (hu)
HU (1) HU224009B1 (hu)
ID (1) ID24597A (hu)
IL (1) IL133004A (hu)
NO (1) NO20000045L (hu)
NZ (1) NZ501165A (hu)
PL (1) PL337925A1 (hu)
PT (1) PT991424E (hu)
RU (1) RU2216354C2 (hu)
SK (1) SK122000A3 (hu)
TR (1) TR199903026T2 (hu)
UA (1) UA64761C2 (hu)
WO (1) WO1999002189A1 (hu)
ZA (1) ZA985993B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
AU2001238718A1 (en) 2000-03-02 2001-09-12 The Institutes For Pharmaceutical Discovery, Llc Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
JP2005503378A (ja) * 2001-08-06 2005-02-03 ジエノメツド・エル・エル・シー Ａｃｅの過剰に関連する疾患の治療方法及び組成物
AU2002352145A1 (en) * 2001-11-26 2003-06-10 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20140243281A1 (en) 2011-10-28 2014-08-28 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
US20150197536A1 (en) * 2012-07-28 2015-07-16 The Regents Of The University Of Colorado, A Body Corporate Compounds reducing the production of sorbitol in the eye and methods of using the same
CN103063794B (zh) * 2012-12-24 2014-08-06 扬子江药业集团南京海陵药业有限公司 一种依帕司他片的含量检测控制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications

Also Published As

Publication number Publication date
NO20000045D0 (no) 2000-01-06
WO1999002189A1 (en) 1999-01-21
PL337925A1 (en) 2000-09-11
DK0991424T3 (da) 2001-12-03
IL133004A (en) 2004-12-15
IL133004A0 (en) 2001-03-19
GB9714274D0 (en) 1997-09-10
PT991424E (pt) 2002-02-28
HK1028876A1 (en) 2001-03-09
EP0991424B1 (en) 2001-09-12
JP2002509540A (ja) 2002-03-26
DE69801661T2 (de) 2002-07-04
CN1261804A (zh) 2000-08-02
RU2216354C2 (ru) 2003-11-20
AU8229698A (en) 1999-02-08
CA2292451A1 (en) 1999-01-21
DE69801661D1 (de) 2001-10-18
TR199903026T2 (xx) 2000-04-21
CN1186097C (zh) 2005-01-26
BR9810570A (pt) 2000-09-19
EP0991424A1 (en) 2000-04-12
CZ290276B6 (cs) 2002-06-12
US6337327B1 (en) 2002-01-08
UA64761C2 (uk) 2004-03-15
NO20000045L (no) 2000-01-06
CZ200017A3 (cs) 2000-05-17
ZA985993B (en) 1999-01-18
ATE205402T1 (de) 2001-09-15
SK122000A3 (en) 2000-06-12
ID24597A (id) 2000-07-27
NZ501165A (en) 2001-06-29
KR20010015551A (ko) 2001-02-26
ES2163283T3 (es) 2002-01-16
AU746211B2 (en) 2002-04-18
HU224009B1 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
HUP0002644A2 (hu) Aldóz reduktáz inhibítort és ACE inhibitort tartalmazó gyógyászati készítmények
NO301824B1 (no) 1-benzensulfonyl-1,3-dihydro-indol-2-on-derivater og farmasöytiske blandinger som inneholder dem
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
IL139862A0 (en) Thiazolidine or pyrrolidine derivatives as dipeptidyl peptidase iv effectors and pharmaceutical compositions containing the same
YU30700A (sh) Kombinacija inhibitora aldozo reduktaze i inhibitora glikogen fosforilaze
WO2000056296A3 (en) Compositions for improving fertility
MXPA03000136A (es) Derivados anticonvulsivos utiles para prevenir el desarrollo de la diabetes mellitus de tipo ii o del sindromex.
MY125516A (en) Novel composition based on thiazolidinedione and metformin and use
BG103425A (en) Pharmaceutical composition
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
EP1577308A3 (en) Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
EP1167354A3 (en) Racemic huperzine A
AU9534398A (en) Novel pharmaceutical composition
CA2128711A1 (en) Trypsin inhibitors
AU3864000A (en) Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
AU4466597A (en) Prevention of gastrointestinal damage
GB9930768D0 (en) Composition
AU2001230195A1 (en) Pharmaceutical compositions comprising terbinafine
ATE350064T1 (de) Pharmazeutische zusammensetzungen von rapamycines
WO2001010454A3 (en) Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
WO1994006454A3 (en) Inhibitiion of retrovirus infection

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050301

MM4A Lapse of definitive patent protection due to non-payment of fees